Aleva Neurotherapeutics announced that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
The grant of up to $180,000 is dedicated to development of Aleva’s directSTIMTM device, a complete directional DBS system for sustained therapy in Parkinson’s disease and essential tremor. The funds will go toward the preparation of a clinical study assessing the long-term clinical performance of directSTIMTM in a prospective, single-arm, open trial in people with Parkinson’s disease…
Source: Aleva